Thomas Arnason

Thomas Arnason

Halifax, NS, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Effective allogeneic natural killer cell therapy for pancreatic adenocarcinoma avails conserved activating receptors and evades HLA I-driven inhibition.

Effective allogeneic natural killer cell therapy for pancreatic adenocarcinoma avails conserved activating receptors and evades HLA I-driven inhibition.

Journal: Journal for immunotherapy of cancer

Published: February 07, 2026

Preoperative Soluble AXL in Plasma Predicts Futility of Resecting Pancreatic Ductal Adenocarcinoma.

Preoperative Soluble AXL in Plasma Predicts Futility of Resecting Pancreatic Ductal Adenocarcinoma.

Journal: Current oncology (Toronto, Ont.)

Published: December 14, 2025

Peri-tumoural lymphocyte neighbourhoods predict longer survival in pancreatic ductal adenocarcinoma.

Peri-tumoural lymphocyte neighbourhoods predict longer survival in pancreatic ductal adenocarcinoma.

Journal: Frontiers in immunology

Published: October 23, 2025

Canadian Consensus Recommendations for Predictive Biomarker Testing in Gastric and Gastroesophageal Junction Adenocarcinoma.

Canadian Consensus Recommendations for Predictive Biomarker Testing in Gastric and Gastroesophageal Junction Adenocarcinoma.

Journal: Current oncology (Toronto, Ont.)

Published: October 23, 2024

Glypican-3 and Cytokeratin-19 Expression in Pancreatic Cancer in a Canadian Population.

Glypican-3 and Cytokeratin-19 Expression in Pancreatic Cancer in a Canadian Population.

Journal: Journal of clinical medicine

Published: October 21, 2024

Claudin 18 (43-14A clone) expression in pancreatic ductal adenocarcinoma: Assessment of a potential clinical biomarker for zolbetuximab therapy.

Claudin 18 (43-14A clone) expression in pancreatic ductal adenocarcinoma: Assessment of a potential clinical biomarker for zolbetuximab therapy.

Journal: Translational oncology

Published: October 07, 2024

Improved overall survival in patients with high-grade serous ovarian cancer is associated with CD16a+ immunologic neighborhoods containing NK cells, T cells and macrophages.

Improved overall survival in patients with high-grade serous ovarian cancer is associated with CD16a+ immunologic neighborhoods containing NK cells, T cells and macrophages.

Journal: Frontiers in immunology

Published: October 05, 2023

PAXgene Fixation for Pancreatic Cancer: Implications for Molecular and Surgical Pathology.

PAXgene Fixation for Pancreatic Cancer: Implications for Molecular and Surgical Pathology.

Journal: Journal of clinical medicine

Published: June 02, 2022

A Case of Whipple Disease With Cutaneous Manifestations.

A Case of Whipple Disease With Cutaneous Manifestations.

Journal: The American Journal of dermatopathology

Published: February 19, 2021

Deep learning for computer-assisted diagnosis of hereditary diffuse gastric cancer.

Deep learning for computer-assisted diagnosis of hereditary diffuse gastric cancer.

Journal: Journal of pathology and translational medicine

Published: June 09, 2020

Safety and Feasibility of Using Magnetic Resonance Imaging Criteria to Identify Patients With "Good Prognosis" Rectal Cancer Eligible for Primary Surgery: The Phase 2 Nonrandomized QuickSilver Clinical Trial.

Safety and Feasibility of Using Magnetic Resonance Imaging Criteria to Identify Patients With "Good Prognosis" Rectal Cancer Eligible for Primary Surgery: The Phase 2 Nonrandomized QuickSilver Clinical Trial.

Journal: JAMA oncology

Published: April 12, 2019

Urachal Mucinous Cystic Tumor of Low Malignant Potential with Concurrent Sigmoid Colon Adenocarcinoma.

Urachal Mucinous Cystic Tumor of Low Malignant Potential with Concurrent Sigmoid Colon Adenocarcinoma.

Journal: Case reports in gastrointestinal medicine

Published: February 11, 2019

Showing 1-12 of 44

Last Updated: 09/26/2026